Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 4;6(1):3.
doi: 10.1186/s40621-019-0180-4.

The impact of recreational marijuana commercialization on traumatic injury

Affiliations

The impact of recreational marijuana commercialization on traumatic injury

Christine Chung et al. Inj Epidemiol. .

Abstract

Background: The medical legalization of marijuana has been shown to result in an increased risk of motor vehicle injuries. In Colorado, commercialization of recreational marijuana (initiation of retail sales) occurred on January 1, 2014, resulting in the rapid proliferation of its availability. The objective of this study was to determine whether the proportion of injured patients testing positive for marijuana and other drugs changed two years before and two years after commercialization of recreational marijuana in Colorado.

Methods: This retrospective multi-institutional cohort study included all patients admitted with a traumatic injury to six trauma centers (three centers in Colorado and three centers in states without permissive marijuana laws) from 2012 to 2015. The primary outcome was the rate (%) of a positive urine drug screen (UDS) for marijuana. Generalized linear regression models were used to examine the rate of change over time in the pre-commercialization period relative to the post- commercialization period (via an interaction effect), separately for states with and without recreational marijuana legalization.

Results: There were 40,591 trauma admissions. In Colorado, the rate of marijuana detected with UDS decreased over time pre-commercialization; this trend reversed post-commercialization, when marijuana detection rates increased significantly over time (interaction p = 0.004). At non-Colorado hospitals, the rate over time of marijuana detection was significantly reduced post-commercialization relative to the pre-commercialization period (p < 0.001).

Conclusion: There was an overall increased rate over time of marijuana detected among trauma patients at Colorado hospitals but not at non-Colorado hospitals, suggesting an increased use of marijuana or an increased risk of injury while using marijuana following the commercialization of recreational marijuana in Colorado.

Keywords: Activation; Legalization; Marijuana; Urine drug screen.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was IRB approved at all six participating institutions and was granted a waiver of consent and HIPAA authorization at each institution.

Consent for publication

Not applicable.

Competing interests

The authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Population distribution and rate (%) of UDS testing. UDS, urine drug screen; MVC, motor vehicle crash. Activation refers to a full trauma team activation (highest level). Pre, 2012–2013. Post, 2014–2015
Fig. 2
Fig. 2
Colorado trends in urine drug screen (UDS, %) detection of marijuana and other drugs over time across eight six-month periods from 2012 to 2015, before and after commercialization of recreational marijuana
Fig. 3
Fig. 3
Non-Colorado state trends in urine drug screen (UDS, %) detection of marijuana and other drugs over time across eight six-month periods from 2012 to 2015, before and after commercialization of recreational marijuana

References

    1. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536. doi: 10.1136/bmj.e536. - DOI - PMC - PubMed
    1. Asbridge M, Mann R, Cusimano MD, Trayling C, Roerecke M, Tallon JM, et al. Cannabis and traffic collision risk: findings from a case-crossover study of injured drivers presenting to emergency departments. International journal of public health. 2014;59(2):395–404. doi: 10.1007/s00038-013-0512-z. - DOI - PubMed
    1. Aydelotte JD, Brown LH, Luftman KM, Mardock AL, Teixeira PGR, Coopwood B, et al. Crash fatality rates after recreational marijuana legalization in Washington and Colorado. Am J Public Health. 2017;107(8):1329–1331. doi: 10.2105/AJPH.2017.303848. - DOI - PMC - PubMed
    1. Barrio G, Jimenez-Mejias E, Pulido J, Lardelli-Claret P, Bravo MJ, de la Fuente L. Association between cannabis use and non-traffic injuries. Accid Anal Prev. 2012;47:172–176. doi: 10.1016/j.aap.2012.01.002. - DOI - PubMed
    1. Bradford AC, Bradford WD. Medical marijuana Laws reduce prescription medication use in Medicare part D. Health Aff (Millwood) 2016;35(7):1230–1236. doi: 10.1377/hlthaff.2015.1661. - DOI - PubMed

LinkOut - more resources